LAX 201

Drug Profile

LAX 201

Alternative Names: LAX-201

Latest Information Update: 23 Apr 2011

Price : $50

At a glance

  • Originator Amarin Corporation
  • Class Antidepressants
  • Mechanism of Action Adrenergic receptor antagonists; Serotonin uptake inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Depressive disorders

Most Recent Events

  • 08 Nov 2006 Amarin Corporation is seeking partners to commercialise LAX 201 (http://www.amarincorp.com)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top